Possible advance for some late-stage lung cancer patients

July 7, 2014
Possible advance for some late-stage lung cancer patients
Surgical biopsy could pave way for targeted treatments, study says.

(HealthDay)—Surgical biopsy is safe for certain late-stage lung cancer patients and could improve their chances of getting treated with newer types of drugs that target cancer-related genetic mutations, a new small study reveals.

In many cases, is too dangerous for these , so less-invasive methods are used, including fine-needle aspiration and core needle biopsies. However, these less invasive techniques sometimes gather too few tumor cells to perform the molecular testing needed to prescribe newer targeted drugs, the researchers said.

Their study included 25 patients with late-stage non-small cell lung cancer who had surgical biopsies. Most of the biopsies were performed using video-assisted surgery that requires general anesthesia but only small incisions.

Five patients experienced a complication, three of which were minor. Surgical biopsy identified potentially targetable in 19 of the 25 patients, and changed the treatment strategy in more than half.

Ten of the 19 patients were determined to be eligible for enrollment in a clinical trial of targeted drug treatment, according to the study in the July issue of the Journal of Thoracic and Cardiovascular Surgery.

"We will be allowing more people to be eligible for clinical trials, and ultimately that will provide value to the patient and access to treatments they may not have had otherwise," lead author David Cooke, head of general thoracic surgery at the University of California, Davis Medical Center, said in a university news release.

However, surgical biopsy should be used on a late-stage patient only after the case has been reviewed by a team of experts, including lung and cancer specialists, a radiologist and surgeon, he said.

Explore further: Surgical breast biopsy not overused, study suggests

More information: The U.S. National Library of Medicine has more about lung cancer.

Related Stories

Surgical breast biopsy not overused, study suggests

February 1, 2012
Contrary to earlier findings, surgical breast biopsies may not be as overused as previously thought, according to a study in the February issue of the Journal of the American College of Radiology. Surgical breast biopsies ...

Needle biopsy underused in breast cancer diagnosis, negatively impacting diagnosis and care

June 9, 2014
Needle biopsy, the standard of care radiological procedure for diagnosing breast cancer, is underused with too many patients undergoing the more invasive, excisional biopsy to detect their disease, according to research from ...

MRI-guided biopsy for brain cancer improves diagnosis

May 1, 2014
Neurosurgeons at UC San Diego Heath System have, for the first time, combined real-time magnetic resonance imaging (MRI) technology with novel non-invasive cellular mapping techniques to develop a new biopsy approach that ...

Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment

April 23, 2014
The research, published in the journal Oncotarget, explored tumour heterogeneity – where different cells have different appearances or their own DNA signatures within the same cancer. Such differences could make it difficult ...

African American women with breast cancer less likely to have newer, recommended surgical procedure

June 19, 2014
African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, ...

'Liquid biopsy' offers new way to track lung cancer

June 3, 2014
(Medical Xpress)—Scientists have shown how a lung cancer patient's blood sample could be used to monitor and predict their response to treatment – paving the way for personalised medicine for the disease.

Recommended for you

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.